
JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(6), P. 962 - 964
Published: Dec. 1, 2024
Language: Английский
JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(6), P. 962 - 964
Published: Dec. 1, 2024
Language: Английский
Journal of Clinical Oncology, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 21, 2024
PURPOSE Guidelines recommend cardiovascular (CV) risk assessment and counseling for cancer survivors. This study evaluated the automated heart-health (AH-HA) clinical decision support tool to promote provider-patient CV health (CVH) discussions in outpatient oncology. METHODS The AH-HA trial (WF-1804CD), coordinated by Wake Forest National Cancer Institute Community Oncology Research Program Base, randomized practices or usual care (UC) enrolled survivors receiving routine ≥6 months after curative treatment. displayed American Heart Association Life's Simple 7 CVH factors (BMI, physical activity, diet, smoking status, blood pressure, cholesterol, glucose), populated from electronic record (EHR), alongside treatments received with cardiotoxic potential. primary end point was survivor-reported discussion of nonideal missing factors. A mixed-effects logistic regression model assessed effect on discussions, adjusting practice. RESULTS Five UC four 645 (82% breast, 8% endometrial, 5% colorectal, lymphoma, prostate, multiple types) October 1, 2020, February 28, 2023. Most were female (96%; 84% White/non-Hispanic, Black; 3% Hispanic). Nearly all (98%) reported a ≥1 factor compared 55% ( P < .001). average number discussed higher (mean, 4.06 v 1.27; .001), as EHR-documented (3.83 0.77; = .03). Survivors also significantly more likely report recommendation see provider (39%) (25%, .02). Reported recommendations cardiologist low (approximately 6%) did not differ between groups. CONCLUSION effective at promoting during follow-up consult care.
Language: Английский
Citations
5JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(6), P. 879 - 889
Published: Dec. 1, 2024
Cancer survivors face an elevated risk of cardiovascular disease, with physical inactivity after cancer treatment potentially worsening this risk. The aim study was to investigate the association between activity before and a diagnosis for heart disease. A nationwide cohort 269,943 (mean age 56.3, 45.7% men) evaluated adherence 2 years diagnosis. primary outcomes were incidence myocardial infarction (MI), failure (HF), atrial fibrillation. Subdistribution HRs (sHRs) 95% CIs calculated using Gray's method, accounting death as competing Over follow-up period 1,111,329.28 person-years, compared those who remained inactive, persistent associated 20% reduction in MI (sHR: 0.80; CI: 0.70-0.91) 16% HF 0.84; 0.78-0.90). Initiating linked 11% lower 0.89; 0.79-0.99) 13% 0.87; 0.82-0.93). Being active only 0.71-0.91) 6% 0.94; 0.88-1.00). No observed fibrillation Associations varied by site. These findings underscore importance maintaining health suggest that may offer enduring protection against ischemic disease cardiac dysfunction.
Language: Английский
Citations
5JACC CardioOncology, Journal Year: 2025, Volume and Issue: 7(2), P. 122 - 124
Published: Feb. 1, 2025
Citations
0Current Cardiology Reports, Journal Year: 2025, Volume and Issue: 27(1)
Published: April 8, 2025
Language: Английский
Citations
0Heart and Mind, Journal Year: 2025, Volume and Issue: 9(2), P. 115 - 135
Published: March 1, 2025
Abstract As survival rates for cancer patients improve due to advancements in treatment modalities, there is an increasing prevalence of cardiovascular complications, necessitating a comprehensive understanding this intersection. This review aims elucidate the intricate relationship between and disease, highlighting growing concern toxicity associated with therapies. It explores various treatments, including chemotherapy, targeted therapies, radiation, their risks, such as heart failure ischemic disease. In addition, it discusses importance proactive risk assessments ongoing monitoring mitigate adverse outcomes. Strategies prevention management, lifestyle modifications pharmacologic interventions, are also examined support health survivors. Unlike previous reviews, work integrates insights from multidisciplinary collaborations, emphasizing underexplored mechanisms role innovative tools. highlights emerging therapeutic strategies tailored these providing forward-looking perspective critical area research. The need collaborative method that includes oncologists, cardiologists, primary care providers emphasized ensure integrated addresses both health. serves resource healthcare professionals seeking long-term outcomes survivors by recognizing managing risks.
Language: Английский
Citations
0JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(3), P. 473 - 474
Published: June 1, 2024
Language: Английский
Citations
0JACC CardioOncology, Journal Year: 2024, Volume and Issue: 6(6), P. 962 - 964
Published: Dec. 1, 2024
Language: Английский
Citations
0